Overview

Endometrial Effects of Lipiodol

Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
0
Participant gender:
Female
Summary
The goal is to investigate whether endometrial flushing with Lipiodol enhances fertility. Therefore, anatomo-pathological, histochemical and transcriptional changes of the endometrium after Lipiodol bathing in a general population of healthy volunteers will be determined.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Universitair Ziekenhuis Brussel
Treatments:
Ethiodized Oil
Criteria
Inclusion Criteria:

- Women aged ≥18 and <36 years

- Regular cycle (25-35 days)

- Signed informed consent

- Participants can be included only once in the trial

- Contraceptive: barrier method only.

Exclusion Criteria:

- known iodine allergy

- Body mass index 30 or ≤18.5

- Smoking

- Previous diagnosis of PCO (Polycystic Ovary Syndrome) (>12 antral follicles in one
ovary, Rotterdam criteria 2003)

- Previous diagnosis of endometriosis, uterine malformations or intrauterine pathologies
(submucosal fibroids, endometrial polyps, and intrauterine adhesions)

- Systemic diseases such as thyroid dysfunction

- Breast-feeding or pregnancy within the last 6 months

- Intrauterine devices (IUD)

- History of recurrent miscarriage

- Known history of infertility

- Previous uterine surgery

- Pregnancy wish during the course of the study

- Women who have been previously enrolled in the trial

- Those unable to comprehend the investigational nature of the proposed study